Skip to content

The Effectiveness of a Self-Care Support Program via Line Official Messaging on Side Effect Management Behaviors in New Cancer Patients Receiving Chemotherapy: A Randomized Controlled Trial

The Effectiveness of a Self-Care Support Program via Line Official Messaging on Side Effect Management Behaviors in New Cancer Patients Receiving Chemotherapy: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250503007
Enrollment
60
Registered
2025-05-03
Start date
2025-05-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Lung cancer Chemotherapy side effects Cancer-related fatigue Mucositis Nausea and vomiting Hair loss Myelosuppression Neoplasms Breast Neoplasms Lung Neoplasms Chemotherapy-Induced Side Effects Self Care Telemedicine Mobile Applications Health Education Fatigue Mucositis Nausea Vomiting Hair Loss Myelosuppression Randomized Controlled Trial

Interventions

Participants will be randomly assigned to one of two parallel groups: an intervention group receiving Line Official-based self-care support messages, and a control group receiving standard nursing car
Experimental Behavioral,No Intervention Behavioral
Line Official Self-Care Support Program,Standard care

Sponsors

Lampang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age between 20 to 65 years 2. Diagnosed with cancer stage I to III 3. New cancer patients receiving chemotherapy regimens such as AC, FAC, CMF, Paclitaxel, 4. Paclitaxel/Carboplatin, Docetaxel, or Docetaxel/Cyclophosphamide 5. Owns a mobile phone with access to the LINE application 6. Able to communicate in Thai (speak, read, and write) 7. Willing to participate in the study

Exclusion criteria

Exclusion criteria: 1. Withdraws from the study 2. Has communication impairments such as hearing, vision, or speech disabilities 3. Experiences disease progression or changes in treatment regimen 4. Receives concurrent chemoradiotherapy (CCRT) 5. Refuses treatment

Design outcomes

Primary

MeasureTime frame
Self-care behavior for managing chemotherapy side effects Baseline and after 3 weeks of intervention Self-care behavior questionnaire developed based on the IMB model

Secondary

MeasureTime frame
Perceived knowledge of side effect management Baseline and after 3 weeks of intervention Structured knowledge questionnaire on chemotherapy side effects

Countries

Thailand

Contacts

Public ContactPaweena Padungsorn

Lampang Cancer Hospital

padungsorn4323@gmail.com054335262

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026